Endometriosis Clinical Trials 2024

What are the top hospitals conducting endometriosis research?

When it comes to advancing the understanding and treatment of endometriosis, several top hospitals are leading the way. At The Pennsylvania State University in University Park, researchers are currently conducting two active clinical trials focused on this complex condition. With a total of two endometriosis trials under their belt since recording their first trial in 2018, they demonstrate a commitment to unraveling the mysteries surrounding endometriosis. Similarly, Penn State Health Milton S. Hershey Medical Center in Hershey also boasts two ongoing endometriosis trials and shares the same number of completed studies. Their contribution began with their first recorded trial in 2020.

Moving westward to Rochester, Minnesota, we find another renowned institution dedicated to tackling endometriosis: Mayo Clinic in Rochester. This prestigious medical center is actively involved in two clinical trials for this condition while having previously accomplished an equal number of investigations thus far; all these endeavors have materialized since initiating their inaugural trial in 2020.

The pursuit of advancements is not limited to large cities alone but extends even further across states like Arizona and California where Chandler and Canoga Park respectively house institutions making significant contributions as well. Chandler has taken up its role by conducting two active clinical tests related specifically to endometriosis; likewise, they have successfully carried out past experiments starting from just last year itself when they recorded their maiden investigation on this subject matter during 2021.The hospital at Canoga Park might exhibit a smaller scale than others mentioned here but does not lag behind regarding dedication towards combating this condition - boasting four previously held accomplishments alongside current involvement within ongoing double cases about Endrometriocosis ; marking its place using contributing research work since backtracking till2017.

These hospitals represent beacons of hope for individuals suffering from endometriosis worldwide as they strive towards better understanding and management strategies for this often misunderstood condition.

Which are the best cities for endometriosis clinical trials?

When it comes to endometriosis clinical trials, several cities have emerged as leaders in research and development. Birmingham, Alabama is at the forefront with 8 active trials focusing on treatments like Elagolix and Relugolix Combination Therapy. Houston, Texas closely follows with 7 ongoing studies exploring options such as Elagolix and OG-6219 Dose 3. Washington, District of Columbia also boasts 7 active trials investigating interventions like Transvaginal photobiomodulation and Plant-based Intervention Group. Additionally, Tampa, Florida offers individuals access to 6 active trials studying therapies including Elagolix and Linzagolix 75 mg. Lastly, Idaho Falls, Idaho provides opportunities for participation in 6 clinical trials involving treatments like Elagolix and Relugolix Combination Tablet or Therapy. These cities serve as hubs of cutting-edge research aimed at improving outcomes for those living with endometriosis.

Which are the top treatments for endometriosis being explored in clinical trials?

Endometriosis, a challenging condition for many women, is the focus of ongoing clinical trials exploring potential treatments. Leading the way is elagolix, currently being investigated in three active endometriosis trials and with an impressive track record of 13 all-time trials since its introduction in 2006. Also showing promise is transvaginal photobiomodulation, undergoing evaluation in one active trial and marking its debut on the scene in 2023. Atorvastatin brings another option to the table with one ongoing trial and two overall endometriosis studies since it was first listed in 2014. Finally, a plant-based intervention group has emerged as a contender with one active trial underway following its initial listing just last year in 2022. These groundbreaking clinical trials offer hope for improved management of this complex condition that affects countless women worldwide.

What are the most recent clinical trials for endometriosis?

Exciting advancements are being made in the field of endometriosis research, with recent clinical trials offering hope for improved treatment options. One promising trial involves the use of a Relugolix Combination Tablet, which is currently in Phase 3. This medication aims to provide relief from the symptoms associated with endometriosis and has shown positive results thus far. Another study focuses on utilizing 18F-fluorofuranylnorprogesterone PET/MRI imaging to better understand and diagnose endometriosis. Additionally, OG-6219 Dose 3 has entered Phase 2 trials as a potential therapeutic option for managing this condition. With these innovative approaches under investigation, there is reason to be optimistic about enhanced care for individuals living with endometriosis.

What endometriosis clinical trials were recently completed?

Recent clinical trials have made significant strides in the field of endometriosis research, bringing hope to those affected by this condition. In August 2020, the University of North carolina completed a trial investigating the potential of 18F-fluoroestradiol. Another noteworthy study was conducted by Bayer and concluded in July 2020, testing BAY1817080 as a potential treatment for endometriosis. Additionally, ObsEva SA wrapped up their trial on a linzagolix tablet in June 2019, while Northwestern University's investigation into ICG reached completion during the same month. These efforts demonstrate ongoing dedication within the medical community to find improved therapies for managing endometriosis and alleviating its impact on patients' lives.